This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pharmanest Ab. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Nils Kållberg: Innovator in Thermogelling Anaesthetic Compositions
Introduction
Nils Kållberg is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of local anaesthetics. His innovative work has led to the development of a unique thermogelling composition that enhances the effectiveness of topical anaesthesia.
Latest Patents
Kållberg holds a patent for "Thermogelling anaesthetic compositions." This invention relates to a thermogelling pharmaceutical composition that comprises local anaesthetics in base form, suitable for topical administration. The composition includes a polyoxyethylene castor oil and one or more surfactants to achieve thermogelling characteristics. This advancement has the potential to improve patient comfort and efficacy in medical procedures requiring local anaesthesia.
Career Highlights
Nils Kållberg is associated with Pharmanest AB, a company dedicated to developing innovative pharmaceutical solutions. His work at Pharmanest has focused on creating effective anaesthetic formulations that can be used in various medical applications. Kållberg's expertise in pharmaceutical sciences has positioned him as a key player in the industry.
Collaborations
Throughout his career, Kållberg has collaborated with esteemed colleagues, including Mark Henrik Sundberg and Arne Brodin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of anaesthetics.
Conclusion
Nils Kållberg's contributions to the development of thermogelling anaesthetic compositions highlight his commitment to advancing medical technology. His innovative approach and collaboration with other professionals in the field continue to pave the way for improved patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile